Your search returned 76 studies. (Get alerts for new studies):
- IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
Conditions: Breast Cancer - Lung Cancer - Melanoma - Pancreatic Cancer - Solid Tumors
1 Location available
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
97 Locations available
- RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
Conditions: Thyroid Cancer
3 Locations available
- Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer
Conditions: Thyroid Cancer
1 Location available
- A Phase I Study of MGAH22 in Patients With Refractory HER2 Positive Cancers
Conditions: Non-Small Cell Lung Neoplasms - Prostate Neoplasms - Bladder Neoplasms - Ovarian Neoplasms - Breast Neoplasms
1 Location available
- To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
Conditions: Sarcoma - Neuroblastoma - Wilms Tumor - Leukemia - Lymphoma - Brain Tumors
1 Location available
- Study of REOLYSIN® in Combination With FOLFIRI in Patients With Oxaliplatin Refractory/Intolerant KRAS Mutant Colorectal Cancer
Conditions: Oxaliplatin Refractory/Intolerant KRAS Mutant Colorectal Cancer
3 Locations available
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer
Conditions: Thyroid Cancer
29 Locations available
- MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer
5 Locations available
- Concurrent Versus Sequential Treatment With Sipuleucel-T and Abiraterone in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Conditions: Prostate Cancer Metastatic - Hormone Refractory Prostate Cancer
13 Locations available
- Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
Conditions: Head and Neck Cancer - Kidney Cancer - Liver Cancer - Sarcoma
48 Locations available
- Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma
Conditions: Cancer
3 Locations available
- Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
Conditions: B-cell Chronic Lymphocytic Leukemia - Hematopoietic/Lymphoid Cancer - Prolymphocytic Leukemia - Recurrent Small Lymphocytic Lymphoma - Refractory Chronic Lymphocytic Leukemia
1 Location available
- RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder
Conditions: Bladder Cancer
1 Location available
- Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer
1 Location available
- Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma
Conditions: Bladder Cancer
1 Location available
- Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Conditions: Brain and Central Nervous System Tumors - Metastatic Cancer
2 Locations available
- Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
1 Location available
- A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
1 Location available
- Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade
Conditions: Prostate Cancer
1 Location available
- Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Conditions: Extragonadal Germ Cell Tumor - Ovarian Cancer - Testicular Germ Cell Tumor
9 Locations available
- Genetically Engineered Lymphocyte Therapy in Treating Patients With B-Cell Leukemia or Lymphoma That is Resistant or Refractory to Chemotherapy
Conditions: Hematopoietic/Lymphoid Cancer - Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - B-cell Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 F
1 Location available
- TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Conditions: Hormone Refractory Prostate Cancer
6 Locations available
- MEK Inhibitor AZD6244 and Cetuximab Treating Patients With Advanced or Refractory Solid Tumors That Cannot Be Removed By Surgery
Conditions: Colorectal Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Leukemia - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
22 Locations available
- A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
10 Locations available
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
Conditions: Testicular Cancer - Germ Cell Neoplasm
1 Location available
- Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Conditions: Leukemia-relapsed or Refractory - Cancer
13 Locations available
- Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
Conditions: Thyroid Cancer
1 Location available
- Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
Conditions: Lung Cancer
2 Locations available
- Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer
3 Locations available
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Neuroblastoma - Sarcoma
1 Location available
- Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Conditions: Kidney Neoplasms - Kidney (Renal Cell) Cancer
1 Location available
- Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Trail of Taxotere Plus Sunitinib on Newly Diagnosed, Hormone Refractory, Metastatic Prostate Cancer
Conditions: Prostate Cancer
1 Location available
- Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer
Conditions: Hormone Refractory Prostate Cancer
1 Location available
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer, Squamous Cell Carcinoma of the Skin, Carcinoma of the Breast, and Malignant Melanoma
4 Locations available
- Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Conditions: Bladder Cancer - Bladder (Urothelial, Transitional Cell) Cancer - Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) - Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) - Bladder (Urothelial, Transitional Ce
2 Locations available
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
86 Locations available
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors - Breast Cancer - Colorectal Cancer - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma
Conditions: Solid Cancers
2 Locations available
- Olaparib in Combination With Carboplatin for Refractory or Recurrent Women's Cancers
Conditions: Mixed Muellerian Cancer - Cervical Cancer - Ovarian Cancer - Breast Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer - Endometrial Cancer - Carcinosarcoma
1 Location available
- MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer
Conditions: Kidney Cancer
6 Locations available
- A Phase II Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Conditions: Thymoma - Thymus Cancer - Thymic Carcinoma
1 Location available
- Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm
4 Locations available
- Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epitheli
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer
1 Location available
- Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer
Conditions: Hormone Refractory Prostate Cancer
1 Location available
- Randomized Phase II Trial of Trastuzumab or EVEROLIMUS in Hormone-refractory Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Conditions: Melanoma - Carcinoma, Renal Cell
1 Location available
- PD 0332991 in Treating Patients With Refractory Solid Tumors
Conditions: Adult Solid Tumor - Adenocarcinoma of the Colon - Adenocarcinoma of the Rectum - Adult Central Nervous System Germ Cell Tumor - Adult Teratoma - Benign Teratoma - Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - Famili
1 Location available
- 5-Azacytidine and Oxaliplatin With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy
Conditions: Advanced Cancer - Solid Tumor - Lymphoma
1 Location available
- Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer
Conditions: Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Recurrent Prostate Cancer
3 Locations available
- Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma
Conditions: Cancer - Leukemia - Lymphoma
1 Location available
- AZD6244 and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Is Refractory to Gemcitabine Hydro
Conditions: Pancreatic Cancer
2 Locations available
- Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer
Conditions: Recurrent Colon Cancer - Recurrent Rectal Cancer - Stage IVA Colon Cancer - Stage IVA Rectal Cancer - Stage IVB Colon Cancer - Stage IVB Rectal Cancer
2 Locations available
- Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung
Conditions: Lung Cancer
1 Location available
- A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
Conditions: Brain Cancer - Pediatric Cancers
6 Locations available
- AT13387 in Adults With Refractory Solid Tumors
Conditions: Solid Tumors - Breast Cancer
1 Location available
- A Trial of Pasireotide and Everolimus in Adult Patients With Radioiodine-Refractory Differentiated and Medullary Thyroid Cancer
Conditions: Thyroid Cancer
1 Location available
- Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal Cancer
Conditions: Metastatic Colorectal Cancer
1 Location available
- Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer
Conditions: Small Cell Lung Cancer
1 Location available
- Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Childhood Malignant Fibrous Histiocytoma of Bone - Kidney Cancer - Lymphoma - Melanoma (Skin) - Neuroblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor,
3 Locations available
- A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
2 Locations available
- Donor Stem Cell Transplant After Total-Body Irradiation in Treating Patients With Relapsed or Refractory Hematologic Cancer or Acute Myeloid Leukemia
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes
1 Location available
- ABT-888 and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Ovarian Epithelial Cancer or Primary Per
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors Wi
Conditions: Adrenocortical Carcinoma - Gastrointestinal Carcinoid Tumor - Kidney Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
17 Locations available
- Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
Conditions: Prostate Cancer - Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Stage IV Prostate Cancer
1 Location available
- Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
Conditions: Carcinoma, Squamous Cell of the Head and Neck
25 Locations available
- Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
21 Locations available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- Afatinib (BIBW 2992) in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
Conditions: Esophageal Cancer - Gastric Cancer
1 Location available
|